Navigation Links
Henry Schein to Present at the UBS Global Life Sciences Conference
Date:9/17/2010

MELVILLE, N.Y., Sept. 17 /PRNewswire-FirstCall/ -- Henry Schein, Inc., (Nasdaq: HSIC), the largest provider of health care products and services to office-based practitioners, announced today that Steven Paladino, Henry Schein's Executive Vice President and Chief Financial Officer, will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York.

Henry Schein's presentation is scheduled to begin at 9 a.m. EDT and can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations" and following the link for "Webcasts."  A replay will be available on the Web site following the presentation.

About Henry Schein

Henry Schein, a Fortune 500® company and a member of the NASDAQ 100® Index, is recognized for its excellent customer service and highly competitive prices.  The Company's four business groups -- Dental, Medical, International and Technology -- serve more than 600,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions.  The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items.  Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.

Headquartered in Melville, N.Y., Henry Schein employs more than 13,500 people and has operations or affiliates in 23 countries.  The Company's net sales reached a record $6.5 billion in 2009.  For more information, visit the Henry Schein Web site at www.henryschein.com.


'/>"/>
SOURCE Henry Schein, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 13th Annual Henry Schein Back-to-School Program Serves Record Number of Children
2. Henry Schein Provides Health Care Products for Relief After Flooding in Pakistan
3. Pharmacovigilance Breakthrough: Henry Ford Health System Partners with Rexam and Med Time Technology to Remind Patients to Take Prescription Medication "As Prescribed" to reduce $300 Billion National Healthcare Problem
4. Henry Schein to Present at the Goldman Sachs 31st Annual Global Healthcare Conference
5. Henry Schein Disaster Relief Hotline Stands Ready to Support Dental, Medical and Animal Health Customers
6. Henry Schein Announces the Launch of Innovative Henry Schein ConnectHealth(TM) Collaborative
7. Henry Schein Announces New Strategic Partnership With Brain-Pad(R)
8. Henry Schein to Present at the Deutsche Bank Small and Mid Cap Conference
9. Henry Schein to Present at the UBS 20th Annual Global Healthcare Services Conference
10. Henry Schein To Present At The Jefferies 2010 Global Healthcare Services Conference
11. Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 2016  The ALS Association, in partnership with ALS Finding ... generate a biomarker to track TDP43 aggregation. The successful team(s) ... $1 million investment. --> ... nerve cells in the brain and the spinal cord. Eventually, ... muscle movement, which often leads to total paralysis and death ...
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... CORAL SPRINGS, Florida , February 10, 2016 ... Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, ... Medivation, Inc. (NASDAQ: MDVN ), Adamas Pharmaceuticals, Inc. (NASDAQ: ... ). --> Today,s latest Orphan Drug Designations become ... granted by the FDA to novel drugs and biologics which ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... ... as the World Molecular Imaging Congress (WMIC), will be held in New York ... meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging ...
(Date:2/10/2016)... Rancho Mirage, California (PRWEB) , ... February 10, ... ... Care Dental are working together to expand dental health services to the developmentally ... have moved We Care Dental’s operations to a new facility at 71-949 Highway ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy ... to associations of medical professionals throughout the country. The Guard was specifically designed ... policies and procedures, employee training, regulatory updates, and compliance coaching. , In addition ...
(Date:2/10/2016)... Thornton, CO (PRWEB) , ... February 10, 2016 , ... ... to announce the practice is now accepting new dental patients and families in the ... expect exceptional dental care services from cleanings to cosmetic dentistry, and all in the ...
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral ... December 31, 2015 on Monday, February 29, 2016 after the market closes. , The ... release at 4:30 PM ET. Investors interested in participating by phone are invited to ...
Breaking Medicine News(10 mins):